Table of Content




1. Introduction
1.1. Definition of Nuclear Medicine
1.2. Scope of the Report
1.3. Research Methodology


2. Executive Summary
2.1. Key Findings
2.2. Market Snapshot
2.3. Key Trends


3. Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Chronic Diseases
3.1.2. Growing Adoption of Precision Medicine
3.1.3. Advancements in Imaging Technology
3.1.4. Increasing Demand for Early Disease Diagnosis
3.2. Market Restraints
3.2.1. High Cost of Nuclear Medicine Procedures
3.2.2. Regulatory and Safety Concerns
3.2.3. Limited Availability of Radioisotopes
3.3. Market Opportunities
3.3.1. Development of Novel Radiopharmaceuticals
3.3.2. Expanding Applications in Oncology and Neurology
3.3.3. Strategic Collaborations and Partnerships


4. North America Nuclear Medicine Market Analysis
4.1. Market Size and Forecast (2024-2034)
4.2. Market Share Analysis by:
4.2.1. Product
4.2.1.1. Diagnostics
4.2.1.1.1. SPECT
4.2.1.1.2. PET
4.2.1.2. Therapeutics
4.2.1.2.1. Alpha Emitters
4.2.1.2.2. Beta Emitters
4.2.2. Application
4.2.2.1. Neurology
4.2.2.2. Cardiology
4.2.2.3. Oncology
4.2.2.4. Others
4.2.3. End User
4.2.3.1. Hospitals & Clinics
4.2.3.2. Diagnostic Centers
4.2.3.3. Others
4.3. Value Chain Analysis
4.4. SWOT Analysis
4.5. Porter’s Five Forces Analysis


5. Regional Market Analysis
5.1. United States
5.1.1. Market Overview
5.1.2. Market Size and Forecast
5.1.3. Key Trends
5.1.4. Competitive Landscape
5.2. Canada
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.2.3. Key Trends
5.2.4. Competitive Landscape
5.3. Mexico
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.3.3. Key Trends
5.3.4. Competitive Landscape


6. Competitive Landscape
6.1. Market Share Analysis of Key Players
6.2. Company Profiles of Key Players
6.2.1. GE Healthcare
6.2.2. Siemens Healthineers
6.2.3. Philips Healthcare
6.2.4. Cardinal Health
6.2.5. Lantheus Medical Imaging, Inc.
6.2.6. Curium Pharma
6.2.7. Jubilant Radiopharma
6.2.8. Bracco Imaging S.p.A.
6.2.9. Advanced Accelerator Applications (a Novartis company)
6.2.10. Theragnostics
6.3. Recent Developments and Innovations
6.4. Strategic Initiatives


7. Future Outlook and Market Forecast
7.1. Market Growth Prospects
7.2. Technological Trends and Innovations
7.3. Investment Opportunities
7.4. Strategic Recommendations


8. Key Insights and Reiteration of Main Findings

9. Future Prospects for the North America Nuclear Medicine Market



List of Figures

List of Figures:

Figure 1: North America Nuclear Medicine Market: Market Segmentation
Figure 2: North America Nuclear Medicine Market: Research Methodology
Figure 3: Top Down Approach
Figure 4: Bottom Up Approach
Figure 5: Data Triangulation and Validation
Figure 6: North America Nuclear Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 7: North America Nuclear Medicine Market: Porter’s Five Forces Model Analysis
Figure 8: North America Nuclear Medicine Market: Value Chain Analysis
Figure 9: North America Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 10: North America Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 11: North America Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 12: United States Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 13: United States Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 14: United States Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 15: Canada Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 16: Canada Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 17: Canada Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 18: Mexico Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 19: Mexico Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 20: Mexico Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 21: North America Nuclear Medicine Market: Competitive Benchmarking
Figure 22: North America Nuclear Medicine Market: Vendor Share Analysis, 2024
Figure 23: North America Nuclear Medicine Market: Regulatory Landscape
Figure 24: North America Nuclear Medicine Market: Technological Innovations
Figure 25: North America Nuclear Medicine Market: Sustainability Trends
Figure 26: North America Nuclear Medicine Market: Future Outlook
Figure 27: North America Nuclear Medicine Market: Forecast Methodology

List of Tables

List of Tables:

Table 1: North America Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 2: North America Nuclear Medicine Market, By Diagnostics, 2024-2034 (USD Million)
Table 3: North America Nuclear Medicine Market, By Therapeutics, 2024-2034 (USD Million)
Table 4: North America Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 5: North America Nuclear Medicine Market Revenue by Country, 2024-2034 (USD Million)
Table 6: United States Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 7: United States Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 8: Canada Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 9: Canada Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 10: Mexico Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 11: Mexico Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 12: North America SPECT Diagnostics Market Revenue by Country, 2024-2034 (USD Million)
Table 13: North America PET Diagnostics Market Revenue by Country, 2024-2034 (USD Million)
Table 14: North America Alpha Emitters Therapeutics Market Revenue by Country, 2024-2034 (USD Million)
Table 15: North America Beta Emitters Therapeutics Market Revenue by Country, 2024-2034 (USD Million)
Table 16: North America Hospitals & Clinics Market Revenue by Country, 2024-2034 (USD Million)
Table 17: North America Diagnostic Centers Market Revenue by Country, 2024-2034 (USD Million)
Table 18: North America Nuclear Medicine Market Revenue by Major Companies, 2024-2034 (USD Million)
Table 19: North America Nuclear Medicine Market Volume by Major Companies, 2024-2034 (Units)
Table 20: Siemens Healthineers AG: Company Snapshot
Table 21: Siemens Healthineers AG: Operating Segments
Table 22: Siemens Healthineers AG: Product Portfolio
Table 23: GE Healthcare: Company Snapshot
Table 24: GE Healthcare: Operating Segments
Table 25: GE Healthcare: Product Portfolio
Table 26: Cardinal Health, Inc.: Company Snapshot
Table 27: Cardinal Health, Inc.: Operating Segments
Table 28: Cardinal Health, Inc.: Product Portfolio